Moffitt researchers identify why CAR T therapy may fail in some lymphoma patients

(H. Lee Moffitt Cancer Center & Research Institute) In a new study published in Blood, the official journal of the American Society of Hematology, Moffitt researchers show that immune dysregulation can directly affect the efficacy of CAR T therapy in patients with diffuse large B-cell lymphoma.